Health Canada

Health Canada

March 21, 2008 11:12 ET

Health Canada Warns Consumers not to Use a Certain Lot of PediaCol Due to Health Risk

OTTAWA, ONTARIO--(Marketwire - March 21, 2008) - Health Canada is warning parents and caregivers not to use a certain lot of PediaCol drops, a product for infants taken orally to relieve symptoms of excess gas associated with colic. The product, labelled with the lot number PDC701, was found to be contaminated with yeast and may pose serious health risks. Due to their immature immune systems, infants and young children may be at risk of adverse health effects. Children with weakened immune systems are particularly vulnerable to the potential health risks.

In general, symptoms of exposure to products contaminated with yeast may include, but are not limited to, nausea, vomiting, diarrhea, fever, weight loss, lethargy, coughing, or decreased appetite. For children with weakened immune systems the effects may be more serious.

Euro-Pharm International Canada Inc. has initiated a recall of the product. The Drug Identification Number (DIN) is 02245510 and the affected lot number of the product is PDC701, both of which and can be found on the product label. PediaCol is available at pharmacies across Canada, and over the Internet. Health Canada will monitor the effectiveness of this recall.

Health Canada advises retailers to remove the affected lot of PediaCol from their shelves, and consumers should return the product to the place of purchase. As a precautionary measure, consumers should also discard any bottles that may have been used to store or administer the product. Parents and caregivers who have administered the product to an infant and have health concerns should consult with a health care professional.

This warning may be updated if necessary as further information becomes available. Consumers requiring more information about this advisory can contact Health Canada(s public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.

To report a suspected adverse reaction to this health product, please contact the Canada Vigilance Program of Health Canada by one of the following methods:

Telephone: 1-866-234-2345

Facsimile: 1-866-678-6789

Canada Vigilance Program

Marketed Health Products Directorate

Ottawa, Ontario, AL 0701C

K1A 0K9

E-mail: CanadaVigilance@hc-sc.gc.ca

The Canada Vigilance adverse reaction reporting form, including a version that can be completed and submitted online, is located in the MedEffect area of the Health Canada Web site.

Egalement disponible en français

Contact Information

  • Media Inquiries:
    Health Canada
    613-957-2983
    or
    Public Inquiries:
    613-957-2991
    1-866-225-0709